HSANZ Free Communications 10: Non-malignant haematology
Tracks
HSANZ
| Tuesday, October 20, 2026 |
| 10:30 AM - 12:00 PM |
Speaker
Mr Andrew Gray
Medical`
Sobi Australia
Sustained long-term real-world effectiveness and safety of pegcetacoplan in patients with PNH: ongoing COMPLETE Phase 4 study
10:30 AM - 10:45 AM
Prof Graham Lieschke
Group Leader
Australian Regenerative Medicine Institute / Royal Melbourne Hospital / Peter MacCallum Cancer Centre
Diamond Blackfan anaemia resulting from polyadenylation variants
10:45 AM - 11:00 AM
Dr Marie-Elle Ajaka
Clinical Trial Coordinator
South Western Sydney Local Health District
Evaluating a novel FcRn blocking monoclonal antibody as a preventive strategy in red cell alloimmunised pregnancies at risk of severe HDFN
11:00 AM - 11:15 AM
Dr Hasna Tokhi
Paediatric Haematologist
The Royal Children's Hospital
Initial Reflections following the introduction of Newborn screening for Sickle Cell disease in an Australian population (September 2025-May 2026): A retrospective review of implementation and clinical utility.
11:15 AM - 11:30 AM
Mr Kyle Cavanagh
Medical Student
Australian National University
Insufficient erythropoiesis drives early mortality in warm autoimmune haemolytic anaemia
11:30 AM - 11:45 AM
Dr Evan Zhang
Haematology Advanced Trainee
Prince of Wales Hospital
Endocrinopathy in transfusion-dependent thalassaemia: A retrospective cohort analysis from an Australian Tertiary Referral Centre
11:45 AM - 12:00 PM
